| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |